HIF1A and psoriasis: HIF-1α-dependent glycolysis is implicated in the pathogenesis of Th17 cells; hence, suppressing the activation of HIF-1α and impeding the correlated glycolysis may offer protection in the mouse model of psoriasis (25, 37).